Literature DB >> 9888476

Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045.

G D Wilson1, N Paschoud, J J Pavy, K Weber, P Weber, B Dubray, P A Coucke.   

Abstract

We compared the flow cytometric measurement and analysis of the potential doubling time (Tpot) between three centres involved in the National Cancer Institute (NCI) protocol T92-0045. The primary purpose was to understand and minimize the variation within the measurement. A total of 102 specimens were selected at random from patients entered into the trial. Samples were prepared, stained, run and analysed in each centre and a single set of data analysed by all three centres. Analysis of the disc data set revealed that the measurement of labelling index (LI) was robust and reproducible. The estimation of duration of S-phase (T(S)) was subject to errors of profile interpretation, particularly DNA ploidy status, and analysis. The LI dominated the variation in Tpot such that the level of final agreement, after removal of outliers and ploidy agreement, reached correlation coefficients of 0.9. The sample data showed poor agreement within each of the components of the measurement. There was some improvement when ploidy was in agreement, but correlation coefficients failed to exceed values of 0.5 for Tpot. The data suggest that observer-associated analysis of T(S) and tissue processing and tumour heterogeneity were the major causes of variability in the Tpot measurement. The first two aspects can be standardized and minimized, but heterogeneity will remain a problem with biopsy techniques.

Entities:  

Mesh:

Year:  1999        PMID: 9888476      PMCID: PMC2362202          DOI: 10.1038/sj.bjc.6690052

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report.

Authors:  A C Begg; I Hofland; L Moonen; H Bartelink; S Schraub; P Bontemps; R Le Fur; W Van Den Bogaert; R Caspers; M Van Glabbeke
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-12       Impact factor: 7.038

2.  Loss of local control with prolongation in radiotherapy.

Authors:  J F Fowler; M J Lindstrom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine.

Authors:  R A White; N H Terry
Journal:  Cytometry       Date:  1992

4.  Precision of DNA flow cytometry in inter-institutional analyses.

Authors:  L L Wheeless; J S Coon; C Cox; A D Deitch; R W deVere White; Y Fradet; L G Koss; M R Melamed; M J O'Connell; J E Reeder
Journal:  Cytometry       Date:  1991

5.  Measurement variability in DNA flow cytometry of replicate samples.

Authors:  L L Wheeless; J S Coon; C Cox; A D Deitch; R W de Vere White; L G Koss; M R Melamed; M J O'Connell; J E Reeder; R S Weinstein
Journal:  Cytometry       Date:  1989-11

6.  Improved method for computing potential doubling time from flow cytometric data.

Authors:  R A White; N H Terry; M L Meistrich; D P Calkins
Journal:  Cytometry       Date:  1990

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  How worthwhile are short schedules in radiotherapy? A series of exploratory calculations.

Authors:  J F Fowler
Journal:  Radiother Oncol       Date:  1990-06       Impact factor: 6.280

9.  Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

Authors:  M H Bennett; G D Wilson; S Dische; M I Saunders; C A Martindale; B M Robinson; A E O'Halloran; M D Leslie; J H Laing
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

Authors:  G D Wilson; N J McNally; S Dische; M I Saunders; C Des Rochers; A A Lewis; M H Bennett
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.